Biotech and Money Logo 2018 - Logo.png         Medtech and Money World Congress 2018.png

 

Bringing deals to life.

5-6th February 2018, etc. venues, 200 Aldersgate, St. Pauls, London EC1A 4HD

DOWNLOAD THE BROCHURE
REGISTER NOW

2018 Event Partners

ABOUT THE 2018 WORLD CONGRESS

The 4th annual Biotech and Money / Medtech and Money World Congress is a high-calibre, senior Executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science companies need to enable more effective  investment, business planning and partnering within their businesses.

With our relentless focus on quality peer-2-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we bring together the people that matter to the future of healthcare and life science funding, finance, investment and deal making.

The 2017 conference officially attracted the largest gathering of active Life Science investors in Europe, making it the go to event for Executives looking to engage in investment and partnering discussions. It's the must attend 2018 event for corporates, investors and pharma.

DOWNLOAD THE BROCHURE

 

10 EVENTS IN 1 INCREDIBLE 2-DAY CONGRESS

 

        VIEW THE 2018 BROCHURE FOR

  • - The 2017 event stats 
  • - What's new for February 2018
  • - What makes the 2018 event unique
  • - The 2018 agenda and speakers
  • - Who attended in 2017
  • - Plus much more...
DOWNLOAD THE BROCHURE
BMWC 2018 Brochure

      2018 KEYNOTES AND SPEAKER FACULTY

 

Tony Hickson
Managing Director, Imperial Innovations

Tim Luker

Tim Luker
Director, Eli Lilly

Daniel O'Mahony

Daniel O'Mahony
Partner, Seroba Life Sciences

Christoph Ruedig

Christoph Ruedig
Partner, Albion Ventures

Claudio Rumazza

Claudio Rumazza
Partner, Innogest

Alain Huriez

Alain Huriez
Managing Partner, Advent France Biotechnology

Edoardo Negroni

Edoardo Negroni
Managing Partner, AurorA-TT

Gerry Maguire

Gerry Maguire
General Partner, Atlantic Bridge

Giovanni Mariggi

Giovanni Mariggi
Principal, Medicxi

Edward Van Wezel

Edward Van Wezel
Managing Partner, BioGeneration Ventures

James Shaw

James Shaw
Co-Founder, JAG Shaw Baker

Jean-Philippe Combal

Jean-Philippe Combal
CEO, Vivet Therapeutics

Janke Dittmer

Janke Dittmer
Partner, GildeHealthcare

Jennifer Laird

Jennifer Laird
Senior Director, Eli Lilly & Co.

John Zai

John Zai
CEO, Cocoon Networks

Joachim Rautter

Joachim Rautter
Managing Director, Peppermint

Kate Bingham

Kate Bingham
Managing Partner, SV Health Investors

Johnston Erwin

Johnston Erwin
Vice President, Eli Lilly & Co.

Jonathan Goldstein

Jonathan Goldstein
Director, Boston Scientific Ventures

Martin Frost

Martin Frost
CEO, Cambridge Medical Robotics

Pascale Auge

Pascale Auge
CEO, Inserm Transfert

Onno Van De Stolpe

Onno Van De Stolpe
CEO, Galapagos

Piyush Unalkat

Piyush Unalkat
Head of Technology Transfer, EIF

Thom Rasche

Thom Rasche
Partner, Earlybird Venture Capital

Tommi Lehtonen

Tommi Lehtonen
CEO, Blueprint Genetics

Sander Slootweg

Sander Slootweg
Managing Director, Forbion Capital Partners

Paul Saunders

Paul Saunders
Head of Innovation Investments, Ireland's Strategic Investment Fund

Paul Ashley

Paul Ashley
Head of Technology Transfer, Oxford University Innovation

Chandra Leo

Chandra Leo
Investment Advisor, HBM Partners

Iain Thomas

Iain Thomas
Head of Life Sciences, Cambridge Enterprise

Rob De Ree

Rob De Ree
Chairman, Mellon Medical

Steve Atkinson

Steve Atkinson
CEO, Atlantic Therapeutics

 

CURRENT 2018 BIOTECH AND MEDTECH SHOWCASE COMPANIES

 

ENQUIRE ABOUT A SHOWCASE

2018 EVENT VENUE

Address: etc.venues, 200 Aldersgate,

St. Pauls, London, EC1A 4HD

Email: theteam@etcvenues.co.uk

Phone: +44 (0) 20 7105 6090

CONTACT US

Address : Suite 125, The Business Design Centre, 52 Upper St, London N1 0QH, UK

Email: info@biotechandmoney.com

Phone: +44 (0) 203 637 5908